Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.43
+0.13 (1.78%)
At close: Aug 14, 2026, 4:00 PM EDT
7.44
0.00 (0.07%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Precision BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 86.08 | 110.82 | 85.9 | 116.68 | 189.58 | 143.66 |
Short-Term Investments | 1.47 | 4.76 | 0.41 | - | - | - |
Cash & Short-Term Investments | 87.55 | 115.59 | 86.31 | 116.68 | 189.58 | 143.66 |
Cash Growth | 40.66% | 33.91% | -26.02% | -38.45% | 31.96% | 59.98% |
Accounts Receivable | - | - | 1.7 | 0.9 | 0.72 | 0.49 |
Receivables | - | - | 1.7 | 12.8 | 0.72 | 0.49 |
Prepaid Expenses | 4 | 3.11 | 6.44 | 5.98 | 6.03 | 17.43 |
Other Current Assets | 0.01 | 0.05 | 0.54 | 0.91 | 2.78 | 0.17 |
Total Current Assets | 91.55 | 118.74 | 94.99 | 136.36 | 199.11 | 161.75 |
Property, Plant & Equipment | 6.08 | 7.23 | 10.18 | 14.6 | 13.78 | 29.33 |
Long-Term Investments | 0.74 | 0.74 | 3.21 | 3.21 | 4.75 | 6.84 |
Other Intangible Assets | 1.09 | 1.17 | 0.62 | 0.4 | 0.73 | 2.05 |
Other Long-Term Assets | 26.46 | 26.54 | 22.79 | 0.23 | 12.57 | 4.64 |
Total Assets | 125.92 | 154.42 | 136.39 | 159.78 | 238.17 | 211.5 |
Accounts Payable | 0.83 | 0.3 | 1.31 | 2.97 | 0.65 | 1.14 |
Accrued Expenses | 4.12 | 6.46 | 7.2 | 6.54 | 6.93 | 10.79 |
Short-Term Debt | - | - | - | 22.41 | - | - |
Current Portion of Leases | 1.61 | 1.51 | 1.32 | 1.13 | 1.68 | 1.82 |
Current Unearned Revenue | - | - | 2.96 | 12.04 | 46.19 | 21.24 |
Other Current Liabilities | 0.59 | 0.65 | 2.19 | 4.9 | 4.21 | 0.98 |
Total Current Liabilities | 7.14 | 8.91 | 14.98 | 49.99 | 59.66 | 35.98 |
Long-Term Debt | 22.42 | 22.4 | 22.32 | - | 22.22 | 2.48 |
Long-Term Leases | 4.07 | 4.9 | 6.4 | 7.72 | 1.06 | 4.81 |
Long-Term Unearned Revenue | 10 | 10 | 33.3 | 83.08 | 92.87 | 77.02 |
Other Long-Term Liabilities | 36.99 | 15.95 | 2.99 | 0.13 | 1.92 | 0.04 |
Total Liabilities | 80.63 | 62.17 | 80 | 140.92 | 177.74 | 120.33 |
Common Stock | 0 | 0 | 0 | 0 | 0 | - |
Additional Paid-In Capital | 625.53 | 621.39 | 539.81 | 509.44 | 489.7 | 408.8 |
Retained Earnings | -579.28 | -528.19 | -482.46 | -489.63 | -428.31 | -316.68 |
Treasury Stock | -0.95 | -0.95 | -0.95 | -0.95 | -0.95 | -0.95 |
Total Common Equity | 45.29 | 92.25 | 56.39 | 18.86 | 60.43 | 91.17 |
Shareholders' Equity | 45.29 | 92.25 | 56.39 | 18.86 | 60.43 | 91.17 |
Total Liabilities & Equity | 125.92 | 154.42 | 136.39 | 159.78 | 238.17 | 211.5 |
Total Debt | 28.1 | 28.81 | 30.05 | 31.27 | 24.96 | 9.11 |
Net Cash (Debt) | 59.45 | 86.78 | 56.27 | 85.41 | 164.62 | 134.55 |
Net Cash Growth | 81.26% | 54.22% | -34.12% | -48.12% | 22.35% | 69.72% |
Net Cash Per Share | 2.92 | 6.77 | 8.17 | 22.23 | 56.19 | 68.78 |
Filing Date Shares Outstanding | 27.6 | 24.73 | 10.48 | 6.92 | 3.71 | 2.03 |
Total Common Shares Outstanding | 26.43 | 24.09 | 8.2 | 4.16 | 3.7 | 2.03 |
Working Capital | 84.41 | 109.83 | 80.01 | 86.37 | 139.44 | 125.77 |
Book Value Per Share | 1.71 | 3.83 | 6.87 | 4.53 | 16.34 | 44.91 |
Tangible Book Value | 44.2 | 91.08 | 55.77 | 18.46 | 59.7 | 89.12 |
Tangible Book Value Per Share | 1.67 | 3.78 | 6.80 | 4.43 | 16.14 | 43.90 |
Machinery | - | 17.62 | 18.7 | 19.38 | 20.78 | 22.93 |
Construction In Progress | - | - | 0.01 | 0.07 | 0.52 | 3.04 |
Leasehold Improvements | - | 12.06 | 12.03 | 11.95 | 11.95 | 22.78 |